Jw Pharmac (001060) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.075x

Based on the latest financial reports, Jw Pharmac (001060) has a cash flow conversion efficiency ratio of 0.075x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩27.55 Billion ≈ $18.67 Million USD) by net assets (₩369.37 Billion ≈ $250.32 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Jw Pharmac defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Jw Pharmac - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Jw Pharmac's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jw Pharmac Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jw Pharmac ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Microvast Holdings Inc NASDAQ:MVST	0.009x
Shenzhen HeKeda Precision Cleaning Equipment Co Ltd SHE:002816	-0.058x
AMAROQ MINERALS LTD F:72Q	N/A
Central Garden & Pet Company NASDAQ:CENT	-0.045x
ShaMaran Petroleum Corp V:SNM	0.019x
Shandong Synthesis Electronic Technology Co Ltd SHE:300479	0.008x
China Railway High speed Electrification Equipment Co Ltd SHG:688285	0.024x
Plasson Indus TA:PLSN	0.068x

Annual Cash Flow Conversion Efficiency for Jw Pharmac (2001–2025)

The table below shows the annual cash flow conversion efficiency of Jw Pharmac from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see Jw Pharmac stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩369.37 Billion ≈ $250.32 Million	₩96.40 Billion ≈ $65.33 Million	0.261x	+8.31%
2024-12-31	₩329.49 Billion ≈ $223.29 Million	₩79.39 Billion ≈ $53.80 Million	0.241x	-26.62%
2023-12-31	₩265.44 Billion ≈ $179.89 Million	₩87.16 Billion ≈ $59.07 Million	0.328x	+30.59%
2022-12-31	₩225.76 Billion ≈ $152.99 Million	₩56.76 Billion ≈ $38.47 Million	0.251x	+161.57%
2021-12-31	₩188.54 Billion ≈ $127.77 Million	₩18.12 Billion ≈ $12.28 Million	0.096x	-68.37%
2020-12-31	₩207.47 Billion ≈ $140.60 Million	₩63.05 Billion ≈ $42.73 Million	0.304x	+25.93%
2019-12-31	₩230.09 Billion ≈ $155.93 Million	₩55.53 Billion ≈ $37.63 Million	0.241x	+20.47%
2018-12-31	₩260.11 Billion ≈ $176.27 Million	₩52.11 Billion ≈ $35.31 Million	0.200x	+62.17%
2017-12-31	₩270.78 Billion ≈ $183.50 Million	₩33.45 Billion ≈ $22.67 Million	0.124x	+406.54%
2016-12-31	₩276.31 Billion ≈ $187.25 Million	₩6.74 Billion ≈ $4.57 Million	0.024x	+231.67%
2015-12-31	₩225.41 Billion ≈ $152.75 Million	₩-4.17 Billion ≈ $-2.83 Million	-0.019x	-156.95%
2014-12-31	₩223.83 Billion ≈ $151.68 Million	₩7.28 Billion ≈ $4.93 Million	0.033x	-65.14%
2013-12-31	₩200.74 Billion ≈ $136.04 Million	₩18.72 Billion ≈ $12.69 Million	0.093x	-76.23%
2012-12-31	₩163.66 Billion ≈ $110.91 Million	₩64.21 Billion ≈ $43.52 Million	0.392x	+1233.92%
2006-12-31	₩172.48 Billion ≈ $116.89 Million	₩5.07 Billion ≈ $3.44 Million	0.029x	-95.00%
2005-12-31	₩119.44 Billion ≈ $80.95 Million	₩70.25 Billion ≈ $47.61 Million	0.588x	+367.61%
2004-12-31	₩119.39 Billion ≈ $80.91 Million	₩15.02 Billion ≈ $10.18 Million	0.126x	-16.92%
2003-12-31	₩112.60 Billion ≈ $76.31 Million	₩17.05 Billion ≈ $11.55 Million	0.151x	-46.93%
2002-12-31	₩100.72 Billion ≈ $68.26 Million	₩28.74 Billion ≈ $19.47 Million	0.285x	-43.68%
2001-12-31	₩88.92 Billion ≈ $60.26 Million	₩45.04 Billion ≈ $30.52 Million	0.507x	--

About Jw Pharmac

KO:001060 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$416.42 Million

₩614.47 Billion KRW

Market Cap Rank

#13334 Global

#407 in Korea

Share Price

₩27250.00

Change (1 day)

-2.33%

52-Week Range

₩20950.00 - ₩39050.00

All Time High

₩75306.05